BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10595908)

  • 1. Analysis of E-cadherin in diffuse-type gastric cancer using a mutation-specific monoclonal antibody.
    Becker KF; Kremmer E; Eulitz M; Becker I; Handschuh G; Schuhmacher C; Müller W; Gabbert HE; Ochiai A; Hirohashi S; Höfler H
    Am J Pathol; 1999 Dec; 155(6):1803-9. PubMed ID: 10595908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Novel mutation-specific monoclonal E-cadherin antibodies make possible allele differentiation at the protein level in tumors].
    Becker I; Becker KF; Kremmer E; Eulitz M; Handschuh G; Höfler H
    Verh Dtsch Ges Pathol; 1999; 83():233-9. PubMed ID: 10714216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional allelic loss detected at the protein level in archival human tumours using allele-specific E-cadherin monoclonal antibodies.
    Becker KF; Kremmer E; Eulitz M; Schulz S; Mages J; Handschuh G; Wheelock MJ; Cleton-Jansen AM; Höfler H; Becker I
    J Pathol; 2002 Aug; 197(5):567-74. PubMed ID: 12210074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diffuse stomach carcinoma: from H&E diagnosis and molecular pathology to specific therapy].
    Höfler H
    Verh Dtsch Ges Pathol; 1999; 83():148-54. PubMed ID: 10714205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly specific tumor binding of a 213Bi-labeled monoclonal antibody against mutant E-cadherin suggests its usefulness for locoregional alpha-radioimmunotherapy of diffuse-type gastric cancer.
    Senekowitsch-Schmidtke R; Schuhmacher C; Becker KF; Nikula TK; Seidl C; Becker I; Miederer M; Apostolidis C; Adam C; Huber R; Kremmer E; Fischer K; Schwaiger M
    Cancer Res; 2001 Apr; 61(7):2804-8. PubMed ID: 11306447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor specificity and in vivo targeting of an antibody against exon 9 deleted E-cadherin in gastric cancer.
    Lee HJ; Lee HS; Hur K; Kim WH; Yanagihara K; Becker KF; Lee KU; Yang HK
    J Cancer Res Clin Oncol; 2007 Dec; 133(12):987-94. PubMed ID: 17576594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility.
    Handschuh G; Candidus S; Luber B; Reich U; Schott C; Oswald S; Becke H; Hutzler P; Birchmeier W; Höfler H; Becker KF
    Oncogene; 1999 Jul; 18(30):4301-12. PubMed ID: 10439038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer.
    Ascaño JJ; Frierson H; Moskaluk CA; Harper JC; Roviello F; Jackson CE; El-Rifai W; Vindigni C; Tosi P; Powell SM
    Mod Pathol; 2001 Oct; 14(10):942-9. PubMed ID: 11598162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E-cadherin expression as a differentiation marker in gastric cancer.
    Karayiannakis AJ; Syrigos KN; Chatzigianni E; Papanikolaou S; Karatzas G
    Hepatogastroenterology; 1998; 45(24):2437-42. PubMed ID: 9951940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas.
    Machado JC; Soares P; Carneiro F; Rocha A; Beck S; Blin N; Berx G; Sobrinho-Simões M
    Lab Invest; 1999 Apr; 79(4):459-65. PubMed ID: 10211998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas.
    Becker KF; Atkinson MJ; Reich U; Becker I; Nekarda H; Siewert JR; Höfler H
    Cancer Res; 1994 Jul; 54(14):3845-52. PubMed ID: 8033105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E-cadherin expression in sporadic gastric cancer from Mexico: exon 8 and 9 deletions are infrequent events associated with poor survival.
    Gamboa-Dominguez A; Dominguez-Fonseca C; Chavarri-Guerra Y; Vargas R; Reyes-Gutierrez E; Green D; Quintanilla-Martinez L; Luber B; Busch R; Becker KF; Becker I; Höfler H; Fend F
    Hum Pathol; 2005 Jan; 36(1):29-35. PubMed ID: 15712179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P-cadherin expression in gastric carcinoma: its regulation mechanism and prognostic significance.
    Kim MA; Jung EJ; Lee HS; Lee HE; Yang HK; Oh DY; Bang YJ; Kim WH
    Hum Pathol; 2010 Jun; 41(6):877-85. PubMed ID: 20233621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced activation of epidermal growth factor receptor caused by tumor-derived E-cadherin mutations.
    Bremm A; Walch A; Fuchs M; Mages J; Duyster J; Keller G; Hermannstädter C; Becker KF; Rauser S; Langer R; von Weyhern CH; Höfler H; Luber B
    Cancer Res; 2008 Feb; 68(3):707-14. PubMed ID: 18245470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The normal neuroendocrine cells of the upper gastrointestinal tract lack E-cadherin.
    Waldum HL; Ringnes E; Nordbø H; Sørdal Ø; Nordrum IS; Hauso Ø
    Scand J Gastroenterol; 2014 Aug; 49(8):974-8. PubMed ID: 24742175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined evaluation of mucin antigen and E-cadherin expression may help select patients with gastric cancer suitable for minimally invasive therapy.
    Tanaka M; Kitajima Y; Sato S; Miyazaki K
    Br J Surg; 2003 Jan; 90(1):95-101. PubMed ID: 12520583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between E-cadherin gene mutation and p53 gene mutation, p53 accumulation, Bcl-2 expression and Ki-67 staining in diffuse-type gastric carcinoma.
    Fricke E; Keller G; Becker I; Rosivatz E; Schott C; Plaschke S; Rudelius M; Hermannstädter C; Busch R; Höfler H; Becker KF; Luber B
    Int J Cancer; 2003 Mar; 104(1):60-5. PubMed ID: 12532420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of tumor-associated E-cadherin mutations on tumorigenicity and metastasis.
    Kremer M; Quintanilla-Martinez L; Fuchs M; Gamboa-Dominguez A; Haye S; Kalthoff H; Rosivatz E; Hermannstädter C; Busch R; Höfler H; Luber B
    Carcinogenesis; 2003 Dec; 24(12):1879-86. PubMed ID: 12949051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of the human E-cadherin (CDH1) gene.
    Berx G; Becker KF; Höfler H; van Roy F
    Hum Mutat; 1998; 12(4):226-37. PubMed ID: 9744472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratumoral heterogeneity and inverse correlation between expression of E-cadherin and collagenase type IV in human gastric carcinomas.
    Anzai H; Kitadai Y; Bucana CD; Sanchez R; Omoto R; Fidler IJ
    Differentiation; 1996 May; 60(2):119-27. PubMed ID: 8641546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.